Recall Register

Food, drugs, devices › Leica Microsystems, Inc.

Device recall: Leica Microsystems M220 F12 Microscope Systems

FDA enforcement event 89009 · Class II · initiated 3 Nov 2021 · status Terminated · terminated 18 Jun 2024

DeviceVoluntary: Firm initiated1 product recordBuffalo Grove, IL

FDA enforcement event 89009 is a device recall by Leica Microsystems, Inc. of Buffalo Grove, IL, initiated 3 Nov 2021 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 89% of the 900 device enforcement events initiated in 2021 carry the same class.

Status: Terminated, terminated 18 Jun 2024. Initiation: voluntary: firm initiated. Leica Microsystems, Inc. has 33 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Leica Microsystems, Inc., Buffalo Grove, IL.

Reason for recall

"In May 2021, Leica Microsystems received one (1) complaint pertaining to the M220 F12 Surgical Microscope system. There was no patient injury reported for this complaint. However, the identified defect carries some potential injury risk. In the event that this defect may occur, the M220 optics carrier may unintentionally drop into the surgical field, risking contact with the patient."

Distribution

"Worldwide distribution - US Nationwide distribution in the states of CA, DC, FL, GA, IL, IN, MA, MI, MD, NY, OH, OR, PA, TN, TX, VA, WI, and Puerto Rico. The countries of Albania, Algeria,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0412-2022Leica Microsystems M220 F12 Microscope Systems2,800Class IITerminated29 Dec 2021

Context

89%of 2021 device events are Class II900 events that year
1product record in this eventfirm median: 1
33events on this register for the firm

Other enforcement events for Leica Microsystems, Inc.

InitiatedProduct (first record)TypeClassRecords
21 Nov 2022Leica MICROSYSTEMS Proveo 8, Part Number 10449058, surgical microscope systemDeviceClass II3
26 Aug 2022Leica Surgical Operating Microscopes, ARveo 8, Part Number 10449063DeviceClass II4
30 Jul 2021BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375DeviceClass II1
20 May 2020Leica ARveo and M530 OH6 microscope systems.DeviceClass II1
18 Nov 2019BOND Polymer Refine Detection Kit, Catalog No. DS9800. This detection system is for in vitro diagnostic use. Bond PolymeDeviceClass II1
3 May 2019Leica Cryostats, used to produce frozen sample sections for biological, medical and industrial applications, including iDeviceClass II1
2 Jan 2019Leica M220 F12 surgical microscope The Leica M220 F12 surgical microscope is an optical instrument for improving the visDeviceClass II1
17 Sep 2018BOND Slide Labeler Zebra Printer Model TLP3842 and Model GX4301, for use with BOND-III and BOND-MAX instrumentsDeviceClass II1
4 Sep 2018Leica M525 F20 Surgical Microscope SystemDeviceClass II1
4 Sep 2018Leica HistoCore SPECTRA CV Coverslipper, used in preparation of histological and cytological tissue samples for microscoDeviceClass II1

All 33 events for Leica Microsystems, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "In May 2021, Leica Microsystems received one (1) complaint pertaining to the M220 F12 Surgical Microscope system. There was no patient injury reported for this complaint. However, the identified defect carries some potential injury risk. In the event that this defect may occur, the M220 optics carrier may unintentionally drop into the surgical field, risking contact with the patient."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution - US Nationwide distribution in the states of CA, DC, FL, GA, IL, IN, MA, MI, MD, NY, OH, OR, PA, TN, TX, VA, WI, and Puerto Rico. The countries of Albania, Algeria,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 18 Jun 2024. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.